Repositioning: the fast track to new anti-malarial medicines?

BACKGROUND: Repositioning of existing drugs has been suggested as a fast track for developing new anti-malarial agents. The compound libraries of GlaxoSmithKline (GSK), Pfizer and AstraZeneca (AZ) comprising drugs that have undergone clinical studies in other therapeutic areas, but not achieved appr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lotharius, Julie, Gamo-Benito, Francisco Javier, Angulo-Barturen, Iñigo, Clark, Julie, Connelly, Michele, Ferrer-Bazaga, Santiago, Parkinson, Tanya, Viswanath, Pavithra, Bandodkar, Balachandra, Rautela, Nikhil, Bharath, Sowmya, Duffy, Sandra, Avery, Vicky M, Möhrle, Jörg J, Guy, R Kiplin, Wells, Timothy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021201/
https://www.ncbi.nlm.nih.gov/pubmed/24731288
http://dx.doi.org/10.1186/1475-2875-13-143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4021201/
https://www.ncbi.nlm.nih.gov/pubmed/24731288
http://dx.doi.org/10.1186/1475-2875-13-143

Ejemplares similares